MX2007000893A

MX2007000893A - La hormona liberadora de hormona de crecimiento mejora la respuesta inmune inducida por la vacunacion.

La hormona liberadora de hormona de crecimiento mejora la respuesta inmune inducida por la vacunacion.

Info

Publication number: MX2007000893A
Authority: MX; Mexico
Prior art keywords: ghrh; seqid; nucleic acid; subject; expression construct
Prior art date: 2004-07-23

Application number

MX2007000893A

Other languages

English (en)

Spanish (es)

Inventor

Ruxandra Draghia-Akli

Patricia A Brown

Amir S Khan

William C Davis

Original Assignee

Advisys Inc

Priority date

2004-07-23

Filing date

2005-07-21

Publication date

2007-04-18

2005-07-21 Application filed by Advisys Inc filed Critical Advisys Inc

2007-04-18 Publication of MX2007000893A publication Critical patent/MX2007000893A/es

Links

101710142969 Somatoliberin Proteins 0.000 title claims abstract description 224
239000000095 Growth Hormone-Releasing Hormone Substances 0.000 title claims abstract description 201
238000002255 vaccination Methods 0.000 title claims abstract description 57
102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 title description 197
230000028993 immune response Effects 0.000 title description 5
230000014509 gene expression Effects 0.000 claims abstract description 145
150000007523 nucleic acids Chemical class 0.000 claims abstract description 145
102000039446 nucleic acids Human genes 0.000 claims abstract description 114
108020004707 nucleic acids Proteins 0.000 claims abstract description 114
241001465754 Metazoa Species 0.000 claims abstract description 89
238000000034 method Methods 0.000 claims abstract description 80
238000001727 in vivo Methods 0.000 claims abstract description 41
229960005486 vaccine Drugs 0.000 claims abstract description 41
239000000203 mixture Substances 0.000 claims abstract description 38
241000282414 Homo sapiens Species 0.000 claims abstract description 34
230000004044 response Effects 0.000 claims abstract description 33
208000015181 infectious disease Diseases 0.000 claims abstract description 27
230000002458 infectious effect Effects 0.000 claims abstract description 21
241000283073 Equus caballus Species 0.000 claims abstract description 15
102100022831 Somatoliberin Human genes 0.000 claims abstract 27
210000001519 tissue Anatomy 0.000 claims description 100
238000004520 electroporation Methods 0.000 claims description 92
241000283690 Bos taurus Species 0.000 claims description 47
238000011282 treatment Methods 0.000 claims description 46
108090000765 processed proteins & peptides Proteins 0.000 claims description 41
102000004196 processed proteins & peptides Human genes 0.000 claims description 36
238000012384 transportation and delivery Methods 0.000 claims description 35
210000003205 muscle Anatomy 0.000 claims description 33
229920001184 polypeptide Polymers 0.000 claims description 31
241000700605 Viruses Species 0.000 claims description 24
238000001890 transfection Methods 0.000 claims description 23
244000005700 microbiome Species 0.000 claims description 21
241000589902 Leptospira Species 0.000 claims description 18
239000003814 drug Substances 0.000 claims description 15
210000000663 muscle cell Anatomy 0.000 claims description 15
230000001976 improved effect Effects 0.000 claims description 14
241000282326 Felis catus Species 0.000 claims description 13
241000287828 Gallus gallus Species 0.000 claims description 13
229920002643 polyglutamic acid Polymers 0.000 claims description 13
241000204031 Mycoplasma Species 0.000 claims description 12
241001494479 Pecora Species 0.000 claims description 12
235000013305 food Nutrition 0.000 claims description 12
238000010276 construction Methods 0.000 claims description 10
206010012735 Diarrhoea Diseases 0.000 claims description 9
239000012528 membrane Substances 0.000 claims description 9
241000894006 Bacteria Species 0.000 claims description 8
241000701083 Bovine alphaherpesvirus 1 Species 0.000 claims description 8
241001550390 Leptospira interrogans serovar Canicola Species 0.000 claims description 8
241000589926 Leptospira interrogans serovar Hardjo Species 0.000 claims description 8
241000725643 Respiratory syncytial virus Species 0.000 claims description 8
238000002360 preparation method Methods 0.000 claims description 8
208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 7
230000000149 penetrating effect Effects 0.000 claims description 7
241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 claims description 6
241000282849 Ruminantia Species 0.000 claims description 5
101000825745 Sus scrofa Somatoliberin Proteins 0.000 claims description 5
206010003246 arthritis Diseases 0.000 claims description 5
239000012678 infectious agent Substances 0.000 claims description 5
244000045947 parasite Species 0.000 claims description 5
125000003275 alpha amino acid group Chemical group 0.000 claims 4
238000002203 pretreatment Methods 0.000 claims 2
230000002708 enhancing effect Effects 0.000 abstract description 2
239000013612 plasmid Substances 0.000 description 133
102000018997 Growth Hormone Human genes 0.000 description 132
108010051696 Growth Hormone Proteins 0.000 description 132
210000004027 cell Anatomy 0.000 description 128
239000000122 growth hormone Substances 0.000 description 126
108090000623 proteins and genes Proteins 0.000 description 90
108020004414 DNA Proteins 0.000 description 88
239000013598 vector Substances 0.000 description 58
230000000694 effects Effects 0.000 description 44
238000002347 injection Methods 0.000 description 36
239000007924 injection Substances 0.000 description 36
108091028043 Nucleic acid sequence Proteins 0.000 description 35
102000004169 proteins and genes Human genes 0.000 description 34
235000018102 proteins Nutrition 0.000 description 31
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 29
238000013518 transcription Methods 0.000 description 28
230000035897 transcription Effects 0.000 description 28
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 27
238000002560 therapeutic procedure Methods 0.000 description 26
230000012010 growth Effects 0.000 description 24
241000282412 Homo Species 0.000 description 23
150000001413 amino acids Chemical class 0.000 description 23
230000001404 mediated effect Effects 0.000 description 23
241000282472 Canis lupus familiaris Species 0.000 description 22
210000002966 serum Anatomy 0.000 description 22
238000004519 manufacturing process Methods 0.000 description 21
239000003623 enhancer Substances 0.000 description 20
230000001965 increasing effect Effects 0.000 description 20
230000028327 secretion Effects 0.000 description 19
230000002068 genetic effect Effects 0.000 description 18
239000000427 antigen Substances 0.000 description 17
108091007433 antigens Proteins 0.000 description 17
102000036639 antigens Human genes 0.000 description 17
230000005684 electric field Effects 0.000 description 17
210000000003 hoof Anatomy 0.000 description 16
229940088597 hormone Drugs 0.000 description 16
239000005556 hormone Substances 0.000 description 16
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
230000035772 mutation Effects 0.000 description 16
108091008146 restriction endonucleases Proteins 0.000 description 16
210000002027 skeletal muscle Anatomy 0.000 description 16
241000282887 Suidae Species 0.000 description 15
230000001225 therapeutic effect Effects 0.000 description 15
238000012546 transfer Methods 0.000 description 15
241000699670 Mus sp. Species 0.000 description 14
235000001014 amino acid Nutrition 0.000 description 14
239000013613 expression plasmid Substances 0.000 description 14
239000012634 fragment Substances 0.000 description 14
230000001105 regulatory effect Effects 0.000 description 14
102000004190 Enzymes Human genes 0.000 description 13
108090000790 Enzymes Proteins 0.000 description 13
229940024606 amino acid Drugs 0.000 description 13
210000000987 immune system Anatomy 0.000 description 13
230000006872 improvement Effects 0.000 description 13
239000000047 product Substances 0.000 description 13
108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
241000700159 Rattus Species 0.000 description 12
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
239000013604 expression vector Substances 0.000 description 12
239000003795 chemical substances by application Substances 0.000 description 11
201000010099 disease Diseases 0.000 description 11
229940079593 drug Drugs 0.000 description 11
239000003550 marker Substances 0.000 description 11
206010028980 Neoplasm Diseases 0.000 description 10
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 10
210000004369 blood Anatomy 0.000 description 10
239000008280 blood Substances 0.000 description 10
235000013330 chicken meat Nutrition 0.000 description 10
125000003729 nucleotide group Chemical group 0.000 description 10
230000008488 polyadenylation Effects 0.000 description 10
102000005962 receptors Human genes 0.000 description 10
108020003175 receptors Proteins 0.000 description 10
241000894007 species Species 0.000 description 10
230000009469 supplementation Effects 0.000 description 10
238000013519 translation Methods 0.000 description 10
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
108010000521 Human Growth Hormone Proteins 0.000 description 9
102000002265 Human Growth Hormone Human genes 0.000 description 9
239000000854 Human Growth Hormone Substances 0.000 description 9
108090001061 Insulin Proteins 0.000 description 9
241000699666 Mus <mouse, genus> Species 0.000 description 9
210000003719 b-lymphocyte Anatomy 0.000 description 9
230000004071 biological effect Effects 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 9
239000008103 glucose Substances 0.000 description 9
230000036737 immune function Effects 0.000 description 9
239000002773 nucleotide Substances 0.000 description 9
239000013603 viral vector Substances 0.000 description 9
230000003612 virological effect Effects 0.000 description 9
102000004877 Insulin Human genes 0.000 description 8
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
241000282898 Sus scrofa Species 0.000 description 8
210000001744 T-lymphocyte Anatomy 0.000 description 8
230000004913 activation Effects 0.000 description 8
238000001994 activation Methods 0.000 description 8
238000003556 assay Methods 0.000 description 8
229940125396 insulin Drugs 0.000 description 8
230000007774 longterm Effects 0.000 description 8
238000002703 mutagenesis Methods 0.000 description 8
231100000350 mutagenesis Toxicity 0.000 description 8
230000007170 pathology Effects 0.000 description 8
230000008569 process Effects 0.000 description 8
238000002741 site-directed mutagenesis Methods 0.000 description 8
RVWNMGKSNGWLOL-GIIHNPQRSA-N (2s)-6-amino-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(2-methyl-1h-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Chemical compound C([C@H](N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CN=CN1 RVWNMGKSNGWLOL-GIIHNPQRSA-N 0.000 description 7
108010078791 Carrier Proteins Proteins 0.000 description 7
102000053602 DNA Human genes 0.000 description 7
101000825742 Homo sapiens Somatoliberin Proteins 0.000 description 7
108700019146 Transgenes Proteins 0.000 description 7
238000010521 absorption reaction Methods 0.000 description 7
230000032683 aging Effects 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
230000002238 attenuated effect Effects 0.000 description 7
230000001580 bacterial effect Effects 0.000 description 7
239000002299 complementary DNA Substances 0.000 description 7
230000006870 function Effects 0.000 description 7
108010070965 hexarelin Proteins 0.000 description 7
230000036039 immunity Effects 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
230000001939 inductive effect Effects 0.000 description 7
150000002632 lipids Chemical class 0.000 description 7
210000004698 lymphocyte Anatomy 0.000 description 7
230000007246 mechanism Effects 0.000 description 7
210000003098 myoblast Anatomy 0.000 description 7
230000001817 pituitary effect Effects 0.000 description 7
230000010076 replication Effects 0.000 description 7
108091026890 Coding region Proteins 0.000 description 6
241000588724 Escherichia coli Species 0.000 description 6
238000013459 approach Methods 0.000 description 6
230000008901 benefit Effects 0.000 description 6
210000000170 cell membrane Anatomy 0.000 description 6
230000001684 chronic effect Effects 0.000 description 6
238000011161 development Methods 0.000 description 6
230000018109 developmental process Effects 0.000 description 6
210000003527 eukaryotic cell Anatomy 0.000 description 6
238000000684 flow cytometry Methods 0.000 description 6
238000010255 intramuscular injection Methods 0.000 description 6
239000007927 intramuscular injection Substances 0.000 description 6
210000002510 keratinocyte Anatomy 0.000 description 6
239000003446 ligand Substances 0.000 description 6
239000002502 liposome Substances 0.000 description 6
235000013336 milk Nutrition 0.000 description 6
210000004080 milk Anatomy 0.000 description 6
239000008267 milk Substances 0.000 description 6
230000001114 myogenic effect Effects 0.000 description 6
231100000957 no side effect Toxicity 0.000 description 6
239000002245 particle Substances 0.000 description 6
239000013600 plasmid vector Substances 0.000 description 6
230000009466 transformation Effects 0.000 description 6
238000011144 upstream manufacturing Methods 0.000 description 6
102100039256 Growth hormone secretagogue receptor type 1 Human genes 0.000 description 5
101710202385 Growth hormone secretagogue receptor type 1 Proteins 0.000 description 5
230000005867 T cell response Effects 0.000 description 5
108091036066 Three prime untranslated region Proteins 0.000 description 5
230000009471 action Effects 0.000 description 5
238000010171 animal model Methods 0.000 description 5
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
125000002091 cationic group Chemical group 0.000 description 5
230000004087 circulation Effects 0.000 description 5
230000007423 decrease Effects 0.000 description 5
238000013461 design Methods 0.000 description 5
238000010494 dissociation reaction Methods 0.000 description 5
230000005593 dissociations Effects 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
238000011156 evaluation Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000001415 gene therapy Methods 0.000 description 5
239000003324 growth hormone secretagogue Substances 0.000 description 5
230000010354 integration Effects 0.000 description 5
210000000265 leukocyte Anatomy 0.000 description 5
229920002521 macromolecule Polymers 0.000 description 5
210000004379 membrane Anatomy 0.000 description 5
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
239000011148 porous material Substances 0.000 description 5
230000003578 releasing effect Effects 0.000 description 5
230000000638 stimulation Effects 0.000 description 5
238000007920 subcutaneous administration Methods 0.000 description 5
239000013589 supplement Substances 0.000 description 5
230000032258 transport Effects 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
101710111255 Appetite-regulating hormone Proteins 0.000 description 4
102100033367 Appetite-regulating hormone Human genes 0.000 description 4
108010054147 Hemoglobins Proteins 0.000 description 4
102000001554 Hemoglobins Human genes 0.000 description 4
206010022489 Insulin Resistance Diseases 0.000 description 4
102100037852 Insulin-like growth factor I Human genes 0.000 description 4
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
241000124008 Mammalia Species 0.000 description 4
102000018697 Membrane Proteins Human genes 0.000 description 4
108010052285 Membrane Proteins Proteins 0.000 description 4
108010057464 Prolactin Proteins 0.000 description 4
102100024819 Prolactin Human genes 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
230000009286 beneficial effect Effects 0.000 description 4
230000003115 biocidal effect Effects 0.000 description 4
230000037396 body weight Effects 0.000 description 4
201000011510 cancer Diseases 0.000 description 4
238000012512 characterization method Methods 0.000 description 4
210000000349 chromosome Anatomy 0.000 description 4
235000013365 dairy product Nutrition 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
230000005611 electricity Effects 0.000 description 4
230000002124 endocrine Effects 0.000 description 4
238000009472 formulation Methods 0.000 description 4
230000036541 health Effects 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
102000045304 human GHRH Human genes 0.000 description 4
230000005847 immunogenicity Effects 0.000 description 4
238000011534 incubation Methods 0.000 description 4
230000003902 lesion Effects 0.000 description 4
210000004185 liver Anatomy 0.000 description 4
238000005259 measurement Methods 0.000 description 4
108020004999 messenger RNA Proteins 0.000 description 4
102000040430 polynucleotide Human genes 0.000 description 4
108091033319 polynucleotide Proteins 0.000 description 4
239000002157 polynucleotide Substances 0.000 description 4
229940097325 prolactin Drugs 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
238000000926 separation method Methods 0.000 description 4
210000003491 skin Anatomy 0.000 description 4
239000000126 substance Substances 0.000 description 4
230000002792 vascular Effects 0.000 description 4
206010000599 Acromegaly Diseases 0.000 description 3
102000007469 Actins Human genes 0.000 description 3
108010085238 Actins Proteins 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
101000825768 Bos taurus Somatoliberin Proteins 0.000 description 3
241000283707 Capra Species 0.000 description 3
208000006413 Digital Dermatitis Diseases 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
108700039691 Genetic Promoter Regions Proteins 0.000 description 3
101710198286 Growth hormone-releasing hormone receptor Proteins 0.000 description 3
102100033365 Growth hormone-releasing hormone receptor Human genes 0.000 description 3
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 3
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 3
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 3
102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 3
241000699660 Mus musculus Species 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
208000000474 Poliomyelitis Diseases 0.000 description 3
239000004365 Protease Substances 0.000 description 3
108020005091 Replication Origin Proteins 0.000 description 3
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
108010056088 Somatostatin Proteins 0.000 description 3
102000005157 Somatostatin Human genes 0.000 description 3
241000589970 Spirochaetales Species 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
230000002411 adverse Effects 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
238000004820 blood count Methods 0.000 description 3
210000000988 bone and bone Anatomy 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
230000008859 change Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000010367 cloning Methods 0.000 description 3
230000006378 damage Effects 0.000 description 3
230000034994 death Effects 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
230000007812 deficiency Effects 0.000 description 3
230000002950 deficient Effects 0.000 description 3
238000009826 distribution Methods 0.000 description 3
230000008030 elimination Effects 0.000 description 3
238000003379 elimination reaction Methods 0.000 description 3
210000002745 epiphysis Anatomy 0.000 description 3
210000003743 erythrocyte Anatomy 0.000 description 3
230000013632 homeostatic process Effects 0.000 description 3
239000002955 immunomodulating agent Substances 0.000 description 3
230000002584 immunomodulator Effects 0.000 description 3
229940121354 immunomodulator Drugs 0.000 description 3
230000003308 immunostimulating effect Effects 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
238000001802 infusion Methods 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
229930027917 kanamycin Natural products 0.000 description 3
229960000318 kanamycin Drugs 0.000 description 3
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
229930182823 kanamycin A Natural products 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
230000004060 metabolic process Effects 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
210000001087 myotubule Anatomy 0.000 description 3
210000000633 nuclear envelope Anatomy 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
210000003463 organelle Anatomy 0.000 description 3
244000052769 pathogen Species 0.000 description 3
230000003389 potentiating effect Effects 0.000 description 3
210000001948 pro-b lymphocyte Anatomy 0.000 description 3
230000000541 pulsatile effect Effects 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
239000000243 solution Substances 0.000 description 3
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 3
229960000553 somatostatin Drugs 0.000 description 3
PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000011830 transgenic mouse model Methods 0.000 description 3
208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
HRNLPPBUBKMZMT-SSSXJSFTSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2r)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](C)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(=O)[C@H](N)C)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=CC=C1 HRNLPPBUBKMZMT-SSSXJSFTSA-N 0.000 description 2
239000000275 Adrenocorticotropic Hormone Substances 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108010006654 Bleomycin Proteins 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
101800000414 Corticotropin Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
-1 DNA Chemical class 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
241000283086 Equidae Species 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
108091027305 Heteroduplex Proteins 0.000 description 2
108010033040 Histones Proteins 0.000 description 2
101100005713 Homo sapiens CD4 gene Proteins 0.000 description 2
101001053946 Homo sapiens Dystrophin Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
108091061960 Naked DNA Proteins 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
102000043276 Oncogene Human genes 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
206010061902 Pancreatic neoplasm Diseases 0.000 description 2
102000006877 Pituitary Hormones Human genes 0.000 description 2
108010047386 Pituitary Hormones Proteins 0.000 description 2
241001582367 Polia Species 0.000 description 2
108700017836 Prophet of Pit-1 Proteins 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
206010000269 abscess Diseases 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
210000000577 adipose tissue Anatomy 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
238000000540 analysis of variance Methods 0.000 description 2
208000007502 anemia Diseases 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
230000000259 anti-tumor effect Effects 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
238000003149 assay kit Methods 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
238000012742 biochemical analysis Methods 0.000 description 2
239000012620 biological material Substances 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
229960001561 bleomycin Drugs 0.000 description 2
OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
108010006025 bovine growth hormone Proteins 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
244000309466 calf Species 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
230000030833 cell death Effects 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
229960000258 corticotropin Drugs 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
238000012258 culturing Methods 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
238000000586 desensitisation Methods 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
230000037213 diet Effects 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
230000029087 digestion Effects 0.000 description 2
208000023867 digital dermatitis in cattle Diseases 0.000 description 2
238000002651 drug therapy Methods 0.000 description 2
238000001976 enzyme digestion Methods 0.000 description 2
230000001667 episodic effect Effects 0.000 description 2
102000037865 fusion proteins Human genes 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
239000000499 gel Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
108091006104 gene-regulatory proteins Proteins 0.000 description 2
102000034356 gene-regulatory proteins Human genes 0.000 description 2
230000004153 glucose metabolism Effects 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
210000003494 hepatocyte Anatomy 0.000 description 2
230000009001 hormonal pathway Effects 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
239000000960 hypophysis hormone Substances 0.000 description 2
210000003016 hypothalamus Anatomy 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
230000010189 intracellular transport Effects 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
238000011068 loading method Methods 0.000 description 2
238000012153 long-term therapy Methods 0.000 description 2
231100000053 low toxicity Toxicity 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000007726 management method Methods 0.000 description 2
210000003519 mature b lymphocyte Anatomy 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
210000001616 monocyte Anatomy 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
150000002894 organic compounds Chemical class 0.000 description 2
201000002528 pancreatic cancer Diseases 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
229910052698 phosphorus Inorganic materials 0.000 description 2
238000013492 plasmid preparation Methods 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
230000017363 positive regulation of growth Effects 0.000 description 2
229960000208 pralmorelin Drugs 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000004850 protein–protein interaction Effects 0.000 description 2
RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
239000003488 releasing hormone Substances 0.000 description 2
238000009256 replacement therapy Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
208000023504 respiratory system disease Diseases 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
230000000580 secretagogue effect Effects 0.000 description 2
230000000392 somatic effect Effects 0.000 description 2
238000000527 sonication Methods 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
239000000725 suspension Substances 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
238000011269 treatment regimen Methods 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
108700026220 vif Genes Proteins 0.000 description 2
239000002699 waste material Substances 0.000 description 2
230000036642 wellbeing Effects 0.000 description 2
VVJYUAYZJAKGRQ-BGZDPUMWSA-N 1-[(2r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)C1 VVJYUAYZJAKGRQ-BGZDPUMWSA-N 0.000 description 1
PNXSUXRNBHUCSF-HSYVXBRLSA-N 107658-43-5 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)OC(=O)CC[C@@H](C(=O)N[C@@H](C)C(=O)OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O)NC(=O)[C@H](CCC(=O)OC(=O)[C@H](CCC(=O)OC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C1C=NC=N1 PNXSUXRNBHUCSF-HSYVXBRLSA-N 0.000 description 1
IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
108020005345 3' Untranslated Regions Proteins 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
102100022454 Actin, gamma-enteric smooth muscle Human genes 0.000 description 1
101710184997 Actin, gamma-enteric smooth muscle Proteins 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
108010082126 Alanine transaminase Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
102000005427 Asialoglycoprotein Receptor Human genes 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
101001034686 Bos taurus Insulin-like growth factor I Proteins 0.000 description 1
206010006895 Cachexia Diseases 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
206010007558 Cardiac failure chronic Diseases 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102100024649 Cell adhesion molecule 1 Human genes 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
108020004998 Chloroplast DNA Proteins 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
108010041986 DNA Vaccines Proteins 0.000 description 1
230000009946 DNA mutation Effects 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
108010069941 DNA receptor Proteins 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
229940021995 DNA vaccine Drugs 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
102100024746 Dihydrofolate reductase Human genes 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
108050004812 Dopamine receptor Proteins 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
108091035710 E-box Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
208000005189 Embolism Diseases 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
101710147132 Epididymal-specific lipocalin-5 Proteins 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
206010015078 Epiphyses premature fusion Diseases 0.000 description 1
241000160765 Erebia ligea Species 0.000 description 1
102000003951 Erythropoietin Human genes 0.000 description 1
108090000394 Erythropoietin Proteins 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
241000410074 Festuca ovina Species 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
108010087294 GALA peptide Proteins 0.000 description 1
101000597041 Gallus gallus Transcriptional enhancer factor TEF-3 Proteins 0.000 description 1
108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
102400000921 Gastrin Human genes 0.000 description 1
108010052343 Gastrins Proteins 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
101150102363 Ghrh gene Proteins 0.000 description 1
208000002705 Glucose Intolerance Diseases 0.000 description 1
102000005720 Glutathione transferase Human genes 0.000 description 1
108010070675 Glutathione transferase Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
206010056438 Growth hormone deficiency Diseases 0.000 description 1
102100020948 Growth hormone receptor Human genes 0.000 description 1
101710099093 Growth hormone receptor Proteins 0.000 description 1
101710119601 Growth hormone-releasing peptides Proteins 0.000 description 1
101710154606 Hemagglutinin Proteins 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
206010020100 Hip fracture Diseases 0.000 description 1
101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 1
101000976075 Homo sapiens Insulin Proteins 0.000 description 1
101100343328 Homo sapiens LIMK2 gene Proteins 0.000 description 1
101001123448 Homo sapiens Prolactin receptor Proteins 0.000 description 1
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
101000653735 Homo sapiens Transcriptional enhancer factor TEF-1 Proteins 0.000 description 1
206010062767 Hypophysitis Diseases 0.000 description 1
102000015611 Hypothalamic Hormones Human genes 0.000 description 1
108010024118 Hypothalamic Hormones Proteins 0.000 description 1
108010031792 IGF Type 2 Receptor Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
102100025947 Insulin-like growth factor II Human genes 0.000 description 1
102000000704 Interleukin-7 Human genes 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
ZQISRDCJNBUVMM-UHFFFAOYSA-N L-Histidinol Natural products OCC(N)CC1=CN=CN1 ZQISRDCJNBUVMM-UHFFFAOYSA-N 0.000 description 1
ZQISRDCJNBUVMM-YFKPBYRVSA-N L-histidinol Chemical compound OC[C@@H](N)CC1=CNC=N1 ZQISRDCJNBUVMM-YFKPBYRVSA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
101710128836 Large T antigen Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
102000019218 Mannose-6-phosphate receptors Human genes 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
241000701029 Murid betaherpesvirus 1 Species 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101000930477 Mus musculus Albumin Proteins 0.000 description 1
101000574441 Mus musculus Alkaline phosphatase, germ cell type Proteins 0.000 description 1
101100020679 Mus musculus Lcn5 gene Proteins 0.000 description 1
101100521345 Mus musculus Prop1 gene Proteins 0.000 description 1
208000029549 Muscle injury Diseases 0.000 description 1
102100031790 Myelin expression factor 2 Human genes 0.000 description 1
101710107751 Myelin expression factor 2 Proteins 0.000 description 1
206010056677 Nerve degeneration Diseases 0.000 description 1
108090000189 Neuropeptides Proteins 0.000 description 1
241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
101000825739 Ovis aries Somatoliberin Proteins 0.000 description 1
CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
101150054854 POU1F1 gene Proteins 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
208000010886 Peripheral nerve injury Diseases 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
101100388690 Plasmodium falciparum (isolate K1 / Thailand) MEF-1 gene Proteins 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
101710176177 Protein A56 Proteins 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
101000930457 Rattus norvegicus Albumin Proteins 0.000 description 1
101000868151 Rattus norvegicus Somatotropin Proteins 0.000 description 1
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
108700025832 Serum Response Element Proteins 0.000 description 1
208000020221 Short stature Diseases 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
206010071051 Soft tissue mass Diseases 0.000 description 1
101710138332 Somatostatin-2 Proteins 0.000 description 1
ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
108700026226 TATA Box Proteins 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 1
102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 1
101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
238000008050 Total Bilirubin Reagent Methods 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 1
241000589886 Treponema Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
102000013394 Troponin I Human genes 0.000 description 1
108010065729 Troponin I Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
108090000848 Ubiquitin Proteins 0.000 description 1
102000044159 Ubiquitin Human genes 0.000 description 1
206010061577 Ulcer haemorrhage Diseases 0.000 description 1
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
241000544286 Vibrio anguillarum Species 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
108010084455 Zeocin Proteins 0.000 description 1
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
201000005255 adrenal gland hyperfunction Diseases 0.000 description 1
239000000556 agonist Substances 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000003321 amplification Effects 0.000 description 1
239000003263 anabolic agent Substances 0.000 description 1
229940124325 anabolic agent Drugs 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229920006318 anionic polymer Polymers 0.000 description 1
210000004198 anterior pituitary gland Anatomy 0.000 description 1
230000001147 anti-toxic effect Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
229940041181 antineoplastic drug Drugs 0.000 description 1
238000003491 array Methods 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
108010006523 asialoglycoprotein receptor Proteins 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
230000003305 autocrine Effects 0.000 description 1
239000013602 bacteriophage vector Substances 0.000 description 1
210000002469 basement membrane Anatomy 0.000 description 1
210000003651 basophil Anatomy 0.000 description 1
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
238000005452 bending Methods 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
239000003364 biologic glue Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
230000036983 biotransformation Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
238000010322 bone marrow transplantation Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000000872 buffer Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000003560 cancer drug Substances 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
208000002458 carcinoid tumor Diseases 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
108010041776 cardiotrophin 1 Proteins 0.000 description 1
229960004203 carnitine Drugs 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
210000004970 cd4 cell Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
210000003763 chloroplast Anatomy 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
231100000762 chronic effect Toxicity 0.000 description 1
208000020832 chronic kidney disease Diseases 0.000 description 1
208000022831 chronic renal failure syndrome Diseases 0.000 description 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
238000011461 current therapy Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
230000021040 cytoplasmic transport Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
230000000779 depleting effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
108020001096 dihydrofolate reductase Proteins 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
210000001840 diploid cell Anatomy 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000002224 dissection Methods 0.000 description 1
108010093406 dopamine D1A receptor Proteins 0.000 description 1
230000005014 ectopic expression Effects 0.000 description 1
230000002996 emotional effect Effects 0.000 description 1
230000003826 endocrine responses Effects 0.000 description 1
230000012202 endocytosis Effects 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
244000000015 environmental pathogen Species 0.000 description 1
210000003979 eosinophil Anatomy 0.000 description 1
210000001339 epidermal cell Anatomy 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
210000000918 epididymis Anatomy 0.000 description 1
201000010063 epididymitis Diseases 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
229940105423 erythropoietin Drugs 0.000 description 1
230000029142 excretion Effects 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000000835 fiber Substances 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
230000004907 flux Effects 0.000 description 1
102000006815 folate receptor Human genes 0.000 description 1
108020005243 folate receptor Proteins 0.000 description 1
239000004459 forage Substances 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
238000010441 gene drive Methods 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
238000007429 general method Methods 0.000 description 1
229960002989 glutamic acid Drugs 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000003163 gonadal steroid hormone Substances 0.000 description 1
238000011194 good manufacturing practice Methods 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
244000309465 heifer Species 0.000 description 1
239000000185 hemagglutinin Substances 0.000 description 1
238000005534 hematocrit Methods 0.000 description 1
230000002489 hematologic effect Effects 0.000 description 1
230000002439 hemostatic effect Effects 0.000 description 1
244000144980 herd Species 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
102000044162 human IGF1 Human genes 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
208000031424 hyperprolactinemia Diseases 0.000 description 1
230000002267 hypothalamic effect Effects 0.000 description 1
239000000601 hypothalamic hormone Substances 0.000 description 1
229940043650 hypothalamic hormone Drugs 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000002766 immunoenhancing effect Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
210000004969 inflammatory cell Anatomy 0.000 description 1
208000014674 injury Diseases 0.000 description 1
150000002484 inorganic compounds Chemical class 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
230000002608 insulinlike Effects 0.000 description 1
230000003933 intellectual function Effects 0.000 description 1
229940100994 interleukin-7 Drugs 0.000 description 1
230000005865 ionizing radiation Effects 0.000 description 1
210000004153 islets of langerhan Anatomy 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
210000004731 jugular vein Anatomy 0.000 description 1
239000008101 lactose Substances 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
244000144972 livestock Species 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
208000004396 mastitis Diseases 0.000 description 1
239000000463 material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
238000002483 medication Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
230000002438 mitochondrial effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000007479 molecular analysis Methods 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
210000002161 motor neuron Anatomy 0.000 description 1
108010017483 mouse somatostatin receptor 2 Proteins 0.000 description 1
229940031348 multivalent vaccine Drugs 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
239000003471 mutagenic agent Substances 0.000 description 1
231100000707 mutagenic chemical Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
238000011328 necessary treatment Methods 0.000 description 1
230000004770 neurodegeneration Effects 0.000 description 1
230000000955 neuroendocrine Effects 0.000 description 1
210000000607 neurosecretory system Anatomy 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
238000013021 overheating Methods 0.000 description 1
210000002571 pancreatic alpha cell Anatomy 0.000 description 1
230000003076 paracrine Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007310 pathophysiology Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
210000003635 pituitary gland Anatomy 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
235000003784 poor nutrition Nutrition 0.000 description 1
231100000683 possible toxicity Toxicity 0.000 description 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
239000002243 precursor Substances 0.000 description 1
201000009104 prediabetes syndrome Diseases 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
238000009163 protein therapy Methods 0.000 description 1
XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
238000000746 purification Methods 0.000 description 1
229950010131 puromycin Drugs 0.000 description 1
210000003370 receptor cell Anatomy 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
208000001076 sarcopenia Diseases 0.000 description 1
210000003497 sciatic nerve Anatomy 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000009758 senescence Effects 0.000 description 1
208000026777 severe mastitis Diseases 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
230000009576 somatic growth Effects 0.000 description 1
210000001875 somatotroph Anatomy 0.000 description 1
229940063675 spermine Drugs 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
229960001052 streptozocin Drugs 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
230000001839 systemic circulation Effects 0.000 description 1
238000012385 systemic delivery Methods 0.000 description 1
231100000057 systemic toxicity Toxicity 0.000 description 1
230000008685 targeting Effects 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000002992 thymic effect Effects 0.000 description 1
239000005495 thyroid hormone Substances 0.000 description 1
229940036555 thyroid hormone Drugs 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
230000002477 vacuolizing effect Effects 0.000 description 1
239000004474 valine Substances 0.000 description 1
210000000605 viral structure Anatomy 0.000 description 1
230000037314 wound repair Effects 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1